TGA Approval

SEQUASE XR quetiapine (as fumarate) 200 mg modified release tablet blister pack (212513)

ARTG ID

212513

ARTG Name

SEQUASE XR quetiapine (as fumarate) 200 mg modified release tablet blister pack

Sponsor

Luye Pharma Australia Pty Ltd

ARTG Date

July 3, 2014

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

LUYE PHARMA AUSTRALIA PTY LTD

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-CMI-02449-1

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-PI-02657-1

Ingredient Name

quetiapine fumarate

Empowering clinical research with data-driven insights and AI-powered tools.

SEQUASE XR quetiapine (as fumarate) 200 mg modified release tablet blister pack (212513) - TGA 批准文号 | MedPath